Search results
Showing 1 to 3 of 3 results for nonacog alfa
In development [GID-TA11397] Expected publication date: 26 February 2025
Fidanacogene elaparvovec for treating moderately severe to severe haemophilia B [ID4032]
In development [GID-TA11117] Expected publication date: TBC
Etranacogene dezaparvovec for treating moderately severe or severe haemophilia B (TA989)
Evidence-based recommendations on etranacogene dezaparvovec (Hemgenix) for treating moderately severe or severe haemophilia B in adults.